Market Report, "Venezuela Pharmaceuticals & Healthcare Report Q1 2015", published

New trade and cooperative agreements for necessary medicines as well as financial injections into the healthcare system will ease Venezuela's troublesome medicine shortage as well as expand healthcare provision in the short-term. Though, the country's fundamental problems which include an increasing inflation, currency devaluation, and a problematic desire for pharmaceutical self-reliance will continue to significantly impair the development of Venezuela's pharmaceutical and healthcare markets over the long-term.

Headline Expenditure Projections

* Pharmaceuticals: VEB59.85bn (USD9.85bn) in 2013 to VEB96.94bn (USD15.41bn) in 2014; +62% in local currency terms and 56.4% in US dollar terms. Forecast revised upwards from Q 4 14 due to higher inflation forecast.
* Healthcare: VEB108.26bn (USD17.82bn) in 2013 to VEB166.62bn (USD26.48bn) in 2014; +53.9% in local currency terms and 48.6% in US dollar terms. Forecast up due to higher inflation forecast.

Full Report Details at
- http://www.fastmr.com/prod/944827_venezuela_pharmaceuticals_healthcare_report_q1.aspx?afid=301

Risk/Reward Index : Venezuela comes ninth in BMI's RRI matrix for Q115 in America, which ranks pharmaceutical markets according to their attractiveness to multinational drugmakers. Venezuela's pharmaceutical market is expected to grow at double-digit rates through to 2023 in local currency terms, largely due to inflation.

Key Trends And Developments

* In December 2014, the Venezuelan Ministry of Health announced its plans to inject VEB38mn into the country's healthcare system. The Ministry soon after began discussions to finalize the budget plans. The plans will most likely look to increase drug supply as well as strengthen healthcare infrastructure and increase the number of trained healthcare workers in the country.
* In December 2014, Venezuela signed 62 new agreements to strengthen education, trade, energy and healthcare between the two nations. The agreement particularly focuses on the Cuban training of Venezuelan healthcare workers to specialise in various fields.
* In December 2014, Venezuela's...

The Venezuela Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Venezuela Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Venezuela pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Venezuela, to test other views - a key input for successful budgeting and strategic business planning in the Venezuelan pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Egypt Pharmaceuticals & Healthcare Report Q1 2015
- Vietnam Pharmaceuticals & Healthcare Report Q1 2015
- United Arab Emirates Pharmaceuticals & Healthcare Report Q1 2015
- Malaysia Pharmaceuticals & Healthcare Report Q1 2015
- Peru Pharmaceuticals & Healthcare Report Q1 2015